Commissioner-designate Jane Henney signals continuity in centers management.
This article was originally published in The Tan Sheet
Executive Summary
FDA COMMISSIONER NOMINEE HENNEY SIGNALS CONTINUITY, suggesting there will be stability in top-side agency support for the agency's six operating centers. Jane Henney, MD, lists recruiting five of the six center directors among her major accomplishments during her first tour of duty at FDA as deputy commissioner for operations from 1992-1994. The physician directors of the Centers for Drug Evaluation & Research (Janet Woodcock), Biologics Evaluation & Research (Kathryn Zoon) and Devices & Radiologic Health (Bruce Burlington) all were appointed to their positions during Henney's tenure.